We are live on ! Find out more
BPMC

Blueprint Medicines
BPMC

Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

219 hedge funds and large institutions have $3.78B invested in Blueprint Medicines in 2019 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 87 increasing their positions, 56 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

209% more call options, than puts

Call options by funds: $90.8M | Put options by funds: $29.4M

55% more repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 56

3.21% more ownership

Funds ownership: 101.52% → 104.73% (+3.2%)

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

0% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 29

0% less funds holding

Funds holding: 220 → 219 (-1)

19% less capital invested

Capital invested by funds: $4.68B → $3.78B (-$898M)

Holders
219
Holders Change
-1
Holders Change %
-0.45%
% of All Funds
4.8%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.18%
New
29
Increased
87
Reduced
56
Closed
29
Calls
$90.8M
Puts
$29.4M
Net Calls
+$61.4M
Net Calls Change
+$37.8M

Top Buyers

Rank Fund Capital Flow
1
CCM
Cadian Capital Management
New York
+$77.4M
2
Viking Global Investors
Viking Global Investors
Connecticut
+$21.7M
3
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$20.3M
4
HM
HealthCor Management
New York
+$19.6M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$18.2M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$28.5M
2
Invesco
Invesco
Georgia
-$24.3M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$21.1M
4
AG
Artal Group
Luxembourg
-$13M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$12.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Simplex Trading
176
Simplex Trading
Illinois
$161K +$190K +2,198 New
SGAM
177
Smith Group Asset Management
Texas
$139K +$55.3K +640 +51%
WT
178
Whittier Trust
California
$120K +$51.9K +600 +58%
PHK
179
Point72 Hong Kong
Hong Kong
$102K +$120K +1,384 New
IA
180
IFP Advisors
Florida
$94K +$110K +1,278 New
TIM
181
Tortoise Investment Management
New York
$71K – – –
US Bancorp
182
US Bancorp
Minnesota
$71K +$24.8K +287 +43%
LTFS
183
Ladenburg Thalmann Financial Services
Florida
$68K -$14.7K -170 -15%
Rockefeller Capital Management
184
Rockefeller Capital Management
New York
$58K -$1.04K -12 -2%
QT
185
Quantbot Technologies
New York
$36K -$25.9K -300 -38%
Carson Wealth (CWM LLC)
186
Carson Wealth (CWM LLC)
Nebraska
$28K – – –
QCG
187
Quadrant Capital Group
Ohio
$26K – – –
Daiwa Securities Group
188
Daiwa Securities Group
Japan
$23K +$519 +6 +2%
CFGS
189
Concourse Financial Group Securities
Alabama
$22K – – –
AG
190
Advisor Group
Arizona
$21K +$259 +3 +1%
Nisa Investment Advisors
191
Nisa Investment Advisors
Missouri
$21K +$6.92K +80 +40%
WEC
192
Winslow Evans & Crocker
Massachusetts
$18K – – –
RFWA
193
RPg Family Wealth Advisory
Massachusetts
$16.2K – – –
SFS
194
Sowell Financial Services
Arkansas
$14K +$16.4K +190 New
RCM
195
Riverhead Capital Management
Delaware
$10K – – –
TC
196
Truvestments Capital
Florida
$7K -$778 -9 -9%
AIS
197
Accurate Investment Solutions
Pennsylvania
$7K – – –
FMII
198
Farmers & Merchants Investments Inc
Nebraska
$7K – – –
MAM
199
Meeder Asset Management
Ohio
$7K – – –
KTC
200
Kistler-Tiffany Companies
Pennsylvania
$7K +$8.64K +100 New
6 7
8
9 10

BPMC Hedge Fund Activity: Q3 2019 in Review

219 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Blueprint Medicines (BPMC) for Q3 2019, worth a combined $3.78B — down 19% from $4.68B a quarter earlier.

Fund positioning in BPMC was balanced in Q3 2019: 29 funds opened new positions, 29 closed out, 87 added to existing stakes and 56 trimmed.

The largest buyer was Cadian Capital Management, adding an estimated $77.4M. The largest seller was Perceptive Advisors, cutting an estimated $28.5M.

  • 219 institutional investors held Blueprint Medicines (BPMC) as of Q3 2019, down from 220 in Q2 2019.
  • Funds reported $3.78B of Blueprint Medicines stock for Q3 2019, down 19% quarter-over-quarter.
  • 29 funds opened new Blueprint Medicines positions in Q3 2019 and 29 closed out, a net change of 0 holders.
  • The largest Blueprint Medicines buyer in Q3 2019 was Cadian Capital Management, an estimated $77.4M added.
  • The largest Blueprint Medicines seller in Q3 2019 was Perceptive Advisors, an estimated $28.5M sold.

Based on aggregated 13F filings for Q3 2019.